Branded and Biosimilar Ophthalmology
Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£146,579,216
Published
24 Nov 2025
Closes
5 Sept 2025
Procurement details
Source
Pcs
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Aflibercept (Eylea®)
£89,785,600
Supply of Aflibercept (Eylea®) vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as a single supplier framework to a single Framework Participant.
Delivery: Scotland
Lot 2 Aflibercept Biosimilar
£1
Supply of Aflibercept Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to five (5) Framework Participants.
Delivery: Scotland
Lot 3 Ranibizumab vials and Pre-filled Syringes
£5,056,988
Supply of Ranibizumab Branded and Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to two (2) Framework Participants.
Delivery: Scotland
Lot 4 Faricimab (Vabysmo®)
£51,736,628
Supply of Faricimab vials and Pre-filled Syringes to NHS Scotland. The Authority has not awarded this Framework to any suppliers.
Delivery: Scotland
Documents
Unlock document linkBranded and Biosimilar Ophthalmology
Not provided
Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
Contract notice · Web page
Branded and Biosimilar Ophthalmology
Not provided
Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.